Nuveen’s Select Medical SEM Stock Holding History

Nuveen’s Portfolio SEM Stock Details SEM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$6.8M	Buy	411,906 +178,821	+77%	+$2.95M	﹤0.01%	1927
2026 Q1	$3.8M	Buy	233,085 +5,422	+2%	+$84.8K	﹤0.01%	1995
2025 Q4	$3.38M	Sell	227,663 -442,430	-66%	-$6.25M	﹤0.01%	2083
2025 Q3	$8.6M	Buy	670,093 +109,910	+20%	+$1.46M	﹤0.01%	1635
2025 Q2	$8.5M	Sell	560,183 -166,373	-23%	-$2.6M	﹤0.01%	1611
2025 Q1	$12.1M	Sell	726,556 -99,831	-12%	-$1.84M	﹤0.01%	1435
2024 Q4	$15.6M	Sell	826,387 -1,215,490	-60%	-$23.4M	﹤0.01%	1325
2024 Q3	$38.4M	Sell	2,041,877 -756,000	-27%	-$14.5M	0.01%	797
2024 Q2	$52.9M	Buy	2,797,877 +446,757	+19%	+$7.62M	0.02%	601
2024 Q1	$38.2M	Buy	2,351,120 +391,897	+20%	+$5.74M	0.01%	767
2023 Q4	$24.8M	Buy	1,959,223 +303,966	+18%	+$3.84M	0.01%	1010
2023 Q3	$22.5M	Buy	1,655,257 +267,515	+19%	+$4.13M	0.01%	974
2023 Q2	$23.8M	Buy	1,387,742 +5,785	+0.4%	+$89.6K	0.01%	969
2023 Q1	$19.2M	Sell	1,381,957 -16,292	-1%	-$240K	0.01%	1074
2022 Q4	$18.7M	Buy	1,398,249 +195,836	+16%	+$2.53M	0.01%	1085
2022 Q3	$14.3M	Sell	1,202,413 -192,033	-14%	-$2.73M	0.01%	1241
2022 Q2	$17.7M	Sell	1,394,446 -1,232,562	-47%	-$15.8M	0.01%	1125
2022 Q1	$35.7M	Buy	2,627,008 +334,336	+15%	+$4.41M	0.01%	816
2021 Q4	$36.3M	Buy	2,292,672 +208,475	+10%	+$3.56M	0.01%	861
2021 Q3	$40.6M	Sell	2,084,197 -185,045	-8%	-$3.67M	0.01%	801
2021 Q2	$51.7M	Sell	2,269,242 -233,080	-9%	-$4.84M	0.02%	722
2021 Q1	$46M	Sell	2,502,322 -210,992	-8%	-$3.46M	0.01%	767
2020 Q4	$40.4M	Sell	2,713,314 -138,046	-5%	-$1.8M	0.01%	817
2020 Q3	$32M	Sell	2,851,360 -253,828	-8%	-$2.5M	0.01%	787
2020 Q2	$24.6M	Buy	3,105,188 +110,044	+4%	+$912K	0.01%	910
2020 Q1	$24.2M	Buy	2,995,144 +227,360	+8%	+$2.7M	0.01%	800
2019 Q4	$34.8M	Sell	2,767,784 -316,990	-10%	-$3.41M	0.01%	863
2019 Q3	$27.5M	Buy	3,084,774 +21,171	+0.7%	+$185K	0.01%	961
2019 Q2	$26.2M	Buy	3,063,603 +3,000,388	+4,746%	+$23.7M	0.01%	1001
2019 Q1	$480K	Buy	63,215 +22,853	+57%	+$184K	﹤0.01%	836
2018 Q4	$334K	Sell	40,362 -29,004	-42%	-$277K	﹤0.01%	875
2018 Q3	$688K	Sell	69,366 -76,781	-53%	-$795K	﹤0.01%	807
2018 Q2	$1.43M	Buy	146,147 +12,179	+9%	+$120K	0.01%	665
2018 Q1	$1.25M	Buy	+133,968	New	+$1.28M	0.01%	709

Other funds holding SEM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Verition Fund Management Greenwich, Connecticut $19.7B AUM 39.39% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

DAM

Decagon Asset Management London, United Kingdom $525M AUM 50.51% 1-Year Est. Return

PAMP

Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return

Nuveen's SEM Position: Q2 2026 in Review

Nuveen increased its Select Medical (SEM) stake by 77% in Q2 2026, buying an estimated $2.95M and bringing the position to 411,906 shares worth $6.8M. The position accounts for ﹤0.01% of the portfolio, ranked #1927.

Nuveen first reported a position in SEM in Q1 2018 and has held it in 34 quarters since. The position peaked at $52.9M in Q2 2024. 238 funds tracked by Wall St. Rank hold SEM as of Q2 2026.

Nuveen held 411,906 shares of Select Medical worth $6.8M as of Q2 2026.
Nuveen bought 178,821 Select Medical shares in Q2 2026, an estimated $2.95M.
Select Medical made up ﹤0.01% of Nuveen's portfolio in Q2 2026, its #1927 holding.
Nuveen first reported a position in Select Medical in Q1 2018 and has held it in 34 quarters since.
Nuveen's Select Medical position peaked at $52.9M in Q2 2024.
238 funds tracked by Wall St. Rank held Select Medical as of Q2 2026.

Based on Nuveen's 13F filing for Q2 2026, filed 11 Aug 2026.